Trials / NCT02303288
Post-Market Study of the Argus® II Retinal Prosthesis System - France
Completed Observational Natural history / observational
- Sponsor
- Second Sight Medical Products
- Treatment
- Argus II Retinal Prosthesis System
- Gene
- Not stated
- Conditions
- Retinitis Pigmentosa
- Ages
- 25 Years to no upper limit
- Enrollment
- 18 participants
- Started
- 2014-11-20
- Main results expected
- 2018-03-20
- Results posted
- Not yet
- Record last updated
- 2020-06-22
What the study is testing
This is a post-market study of the Argus II Retinal Prosthesis System. The study is being conducted in France. The objective of the study is to obtain data to further demonstrate the effectiveness and evaluate the safety of Argus II System in patients with retinitis pigmentosa who have a bare light perception or worse in both eyes.
Where it runs
France (3)
- Centre Hospitalier Universitaire de Bordeaux, Bordeaux
- Centre hospitalier National d'Ophtalmologie des Quinze-Vingts, Paris
- Hôpitaux Universitaires de Strasbourg, Strasbourg